Inductive
Inductive Bio is a New York-based AI drug discovery company building a virtual lab for small molecule optimization. It pairs medicinal chemists with AI to run millions of in silico ADMET experiments before synthesis. Its Beacon-1 models — trained on a pre-competitive, anonymized data consortium spanning thousands of drug programs — won consecutive first-place finishes in the 2025 Polaris/ASAP and 2026 OpenADMET blind ADMET prediction competitions, beating 370+ submissions including entries from Merck and NVIDIA. Products include the Compass software platform (accessible via API), the Indy AI chemistry assistant, the ADME-One high-throughput profiling service, and Embedded Experts. Founded in 2023 by Josh Haimson and Ben Birnbaum (both formerly Flatiron Health); SOC 2 compliant; backed by Obvious Ventures, a16z Bio+Health, Lux Capital, Bessemer Venture Partners, Character, and S32.
Inductive is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Machine Learning, Drug Discovery, and Biotechnology.
Inductive’s developer surface includes engineering blog and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Company 2
The organization behind the API